View the EVRON 35 registration information details.
Back to drug list
ItemsDrug Registration information
ID1861
No1861
Brand NameEVRON 35
IngredientsETHINYLESTRADIOL BP 0.035 MG, CYPROTERONEACETATE BP 2 MG
Dosage FormTABLETS
Primary PackagingPVC BLISTER
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 10 X 1 X 21'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF MODERATE TO SEVERE ACNE RELATED TO ANDROGEN SENSITIVITY (WITH OR WITHOUT SEBORRHOEA) AND/OR HIRSUTISM, IN WOMEN OF REPRODUCTIVE AGE
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionYELLOW COLORED, ROUND SHAPED, BICONVEX, FILM COATED TABLET
Note
License OwnerMEMESCO CO.,LTD
ManufacturerACCENT PHARMACEUTICALS &DIAGNOSTICS
CountryINDIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No01 I 5672/24
FDD Registration Date26/01/2024
Expiry Date25/01/2027
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA